Selected research
Industry Research
Marine Biomedicine Industry Research Report 2026
Market perspective
The global Marine Biomedicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Marine Biomedicine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Marine Biomedicine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Marine Biomedicine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Marine Biomedicine include Sams, Nofima, NEB, Marinova, Marine Biotech, GlycoMar, BiotechMarine and Aquapharm, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Marine Biomedicine market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Marine Biomedicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Marine Biomedicine Market by Company
Sams
Nofima
NEB
Marinova
Marine Biotech
GlycoMar
BiotechMarine
Aquapharm
Marine Biomedicine Segment by Type
Marine Animal Technolog
Marine Plant Technology
Marine Biomedicine Segment by Application
Drug
Health Care Products
Marine Biomedicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biomedicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Biomedicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biomedicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Marine Biomedicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Animal Technolog
- Marine Plant Technology
Applications
- Drug
- Health Care Products
Companies covered
- Sams
- Nofima
- NEB
- Marinova
- Marine Biotech
- GlycoMar
- BiotechMarine
- Aquapharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Marine Biomedicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Marine Animal Technolog
- 2.2.3 Marine Plant Technology
- 2.3 Marine Biomedicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug
- 2.3.3 Health Care Products
- 2.4 Assumptions and Limitations
3 Marine Biomedicine Breakdown Data by Type
- 3.1 Global Marine Biomedicine Historic Market Size by Type (2021-2026)
- 3.2 Global Marine Biomedicine Forecasted Market Size by Type (2027-2032)
4 Marine Biomedicine Breakdown Data by Application
- 4.1 Global Marine Biomedicine Historic Market Size by Application (2021-2026)
- 4.2 Global Marine Biomedicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Marine Biomedicine Market Perspective (2021-2032)
- 5.2 Global Marine Biomedicine Growth Trends by Region
- 5.2.1 Global Marine Biomedicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Marine Biomedicine Historic Market Size by Region (2021-2026)
- 5.2.3 Marine Biomedicine Forecasted Market Size by Region (2027-2032)
- 5.3 Marine Biomedicine Market Dynamics
- 5.3.1 Marine Biomedicine Industry Trends
- 5.3.2 Marine Biomedicine Market Drivers
- 5.3.3 Marine Biomedicine Market Challenges
- 5.3.4 Marine Biomedicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Marine Biomedicine Players by Revenue
- 6.1.1 Global Top Marine Biomedicine Players by Revenue (2021-2026)
- 6.1.2 Global Marine Biomedicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Marine Biomedicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Marine Biomedicine Head Office and Area Served
- 6.4 Global Marine Biomedicine Players, Product Type & Application
- 6.5 Global Marine Biomedicine Manufacturers Established Date
- 6.6 Global Marine Biomedicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Marine Biomedicine Market Size (2021-2032)
- 7.2 North America Marine Biomedicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Marine Biomedicine Market Size by Country (2021-2026)
- 7.4 North America Marine Biomedicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Marine Biomedicine Market Size (2021-2032)
- 8.2 Europe Marine Biomedicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Marine Biomedicine Market Size by Country (2021-2026)
- 8.4 Europe Marine Biomedicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Marine Biomedicine Market Size (2021-2032)
- 9.2 Asia-Pacific Marine Biomedicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Marine Biomedicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Marine Biomedicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Marine Biomedicine Market Size (2021-2032)
- 10.2 South America Marine Biomedicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Marine Biomedicine Market Size by Country (2021-2026)
- 10.4 South America Marine Biomedicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Marine Biomedicine Market Size (2021-2032)
- 11.2 Middle East & Africa Marine Biomedicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Marine Biomedicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Marine Biomedicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sams
- 12.1.1 Sams Company Information
- 12.1.2 Sams Business Overview
- 12.1.3 Sams Revenue in Marine Biomedicine Business (2021-2026)
- 12.1.4 Sams Marine Biomedicine Product Portfolio
- 12.1.5 Sams Recent Developments
- 12.2 Nofima
- 12.2.1 Nofima Company Information
- 12.2.2 Nofima Business Overview
- 12.2.3 Nofima Revenue in Marine Biomedicine Business (2021-2026)
- 12.2.4 Nofima Marine Biomedicine Product Portfolio
- 12.2.5 Nofima Recent Developments
- 12.3 NEB
- 12.3.1 NEB Company Information
- 12.3.2 NEB Business Overview
- 12.3.3 NEB Revenue in Marine Biomedicine Business (2021-2026)
- 12.3.4 NEB Marine Biomedicine Product Portfolio
- 12.3.5 NEB Recent Developments
- 12.4 Marinova
- 12.4.1 Marinova Company Information
- 12.4.2 Marinova Business Overview
- 12.4.3 Marinova Revenue in Marine Biomedicine Business (2021-2026)
- 12.4.4 Marinova Marine Biomedicine Product Portfolio
- 12.4.5 Marinova Recent Developments
- 12.5 Marine Biotech
- 12.5.1 Marine Biotech Company Information
- 12.5.2 Marine Biotech Business Overview
- 12.5.3 Marine Biotech Revenue in Marine Biomedicine Business (2021-2026)
- 12.5.4 Marine Biotech Marine Biomedicine Product Portfolio
- 12.5.5 Marine Biotech Recent Developments
- 12.6 GlycoMar
- 12.6.1 GlycoMar Company Information
- 12.6.2 GlycoMar Business Overview
- 12.6.3 GlycoMar Revenue in Marine Biomedicine Business (2021-2026)
- 12.6.4 GlycoMar Marine Biomedicine Product Portfolio
- 12.6.5 GlycoMar Recent Developments
- 12.7 BiotechMarine
- 12.7.1 BiotechMarine Company Information
- 12.7.2 BiotechMarine Business Overview
- 12.7.3 BiotechMarine Revenue in Marine Biomedicine Business (2021-2026)
- 12.7.4 BiotechMarine Marine Biomedicine Product Portfolio
- 12.7.5 BiotechMarine Recent Developments
- 12.8 Aquapharm
- 12.8.1 Aquapharm Company Information
- 12.8.2 Aquapharm Business Overview
- 12.8.3 Aquapharm Revenue in Marine Biomedicine Business (2021-2026)
- 12.8.4 Aquapharm Marine Biomedicine Product Portfolio
- 12.8.5 Aquapharm Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst